Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization

Radiology

Volumn 217, Issue 1, 2000, Pages 228-235

  Jha, R C ^a   Ascher, S M ^a   Imaoka, I ^a   Spies, J B ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Arteries, therapeutic blockade; Arteries, uterine; Leiomyoma; Uterine neoplasms; Uterine neoplasms, MR; Uterine neoplasms, therapy

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HUMAN; IMAGE ENHANCEMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; TUMOR VOLUME; UTERUS MYOMA;

EID: 0034538041     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.217.1.r00se49228     Document Type: Article

References (16)

1. Changing trends in treatment of leiomyomata uteri
2. Hysterectomy in the United States
3. Indications and results of total hysterectomy
4. Arterial embolization to treat uterine myomata
5. Preliminary experience with uterine artery embolization for uterine fibroids
6. Transcatheter uterine artery embolisation to treat large uterine fibroids
7. Uterine artery embolization for the management of symptomatic fibroids: Current experience with 125 patients with follow-up of up to one year
8. Transarterial embolization of the uterine arteries: Patient reactions and effects on uterine vasculature
9. Embolic occlusion of the blood supply to uterine myomas: Report of 2 cases
10. Initial results from uterine fibroid embolization for symptomatic leiomyomata
11. The magnetic resonance imaging characteristics of fibroid embolization
12. Uterine arterial embolization for leiomyomas: Monitoring of immediate and late perfusion changes with MRI
13. The measurement of observer agreement for categorical data
14. The blood supply of uterine myomata
15. Estrogen and progesterone receptor content of enucleated uterine myomata after luteinizing hormone-releasing hormone
16. Doppler assessment of Uterine blood flow changes in patients with fibroids receiving the gonadotropin-releasing hormone agonist buserelin